The brand of generic prescriptions

Simple item page
dc.contributor.authorGangadhar, BNen_US
dc.contributor.authorChaturvedi, Santosh Ken_US
dc.date.accessioned2020-04-10T01:24:49Z
dc.date.available2020-04-10T01:24:49Z
dc.date.issued2018-01
dc.description.abstractFor some time now, a debate has been raging on the issue of generic drug prescriptions. Doctors are divided on this matter. Those against generic prescription cite possible poor quality and inadequate testing; while those in favour assert that the move would make cheaper medicines accessible to many more patients. The pharmaceutical industry attempts to introduce drug molecules that are safer and perhaps more effective. To enter the market each molecule would have been subjected to rigorous experimentation, at huge cost which needs to be recovered. The services of the industry are hence to be greatly appreciated, in spite of the criticism of the high pricing of their products.en_US
dc.identifier.affiliationsDirector and Senior Professor of Psychiatry, NIMHANS, Bengaluru 560 029 Karnataka, India, dirstaff@nimhans.ac.inen_US
dc.identifier.affiliationsDean, Behavioural Medicine and Senior Professor of Psychiatry, NIMHANS, Bengaluru 560 029 Karnataka, India, chatur@nimhans.ac.inen_US
dc.identifier.citationGangadhar BN, Chaturvedi Santosh K. The brand of generic prescriptions. Indian Journal of Medical Ethics. 2018 Jan; 3(1): 85en_US
dc.identifier.issn0974-8466 
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/195079
dc.languageenen_US
dc.publisherForum for Medical Ethics Societyen_US
dc.relation.issuenumber1en_US
dc.relation.volume3en_US
dc.source.urihttps://doi.org/10.20529/IJME.2018.006en_US
dc.titleThe brand of generic prescriptionsen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijme2018v3n1p85.pdf
Size:
53.84 KB
Format:
Adobe Portable Document Format
Download
Collections
Indian Journal of Medical Ethics